Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Exercise/Conversion of 1,112 CYTK shares, $53.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | CYTOKINETICS INC (CYTK) | Exercise/Conversion | 1,112 | $53.9K |
| Jun 29, 2026 | CYTOKINETICS INC (CYTK) | Exercise/Conversion | 23,370 | $1.13M |
| Jun 29, 2026 | CYTOKINETICS INC (CYTK) | Exercise/Conversion | 188 | $8.3K |
| Jun 8, 2026 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 570 | n/a |
| May 5, 2026 | CYTOKINETICS INC (CYTK) | Sale | 23,906 | $1.84M |
| May 1, 2026 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 12,300 | n/a |
| Mar 18, 2026 | CYTOKINETICS INC (CYTK) | Sale | 4,935 | $306.7K |
| Mar 17, 2026 | CYTOKINETICS INC (CYTK) | Grant/Award | 20,646 | n/a |
| Jan 6, 2026 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 10,000 | n/a |
| Dec 29, 2025 | CYTOKINETICS INC (CYTK) | Grant/Award | 2,152 | n/a |